Optiver Holding B.V. Obs Eva Sa Transaction History

Optiver Holding B.V.

  • $5.14 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$1.34 - $2.08 $7,675 - $11,914
-5,728 Reduced 38.41%
9,183 $15,000
Q1 2022

May 16, 2022
SELL
$1.1 - $2.17 $5,104 - $10,068
-4,640 Reduced 23.73%
14,911 $22,000
Q3 2021

Nov 15, 2021
BUY
$2.47 - $3.34 $48,290 - $65,300
19,551 New
19,551 $62,000

Others Institutions Holding OBSV

# of Institutions
2
Shares Held
88K
Call Options Held
0
Put Options Held
0
View Full List

About ObsEva SA

OBSV Quotes by TradingView
  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Optiver Holding B.V. Portfolio

Follow Optiver Holding B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

News

Stay updated on Optiver Holding B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email